Biotech Essentials

Career and Jobs

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 11.03.2021.

#CRISPR
#PharmiwebNews
#SARSCoV2
#LifeSciencesNews
#BiotechNews
#ClinicalResearchNews
#HealthcareNews
#PharmaNews
#MedicalNews
#geneediting

Career And Jobs

@NatureBiotech shared
On Mar 10, 2021
@LabRoots Inhaled #CRISPR treatment targets #influenza and #SARSCoV2 infections #NBTintheNews via @GENbio https://t.co/BicD5nTRAK
Open
Inhaled CRISPR Treatment Targets Influenza and SARS-CoV-2 Infections

Inhaled CRISPR Treatment Targets Influenza and SARS-CoV-2 Infections

The treatment uses a type of CRISPR to target viral RNA and appears to stop replication of both viruses in the lungs.

@BiotechWorld shared
On Mar 9, 2021
Ex-Intercept CMO Campagna lands at immune regulation biotech Q32 https://t.co/HgPxRLlxbA https://t.co/xpF7pdL80b
Open
Ex-Intercept CMO Campagna lands at immune regulation biotech Q32

Ex-Intercept CMO Campagna lands at immune regulation biotech Q32

Jason Campagna has taken up the chief medical officer position (CMO) at Q32 Bio. Campagna arrives at Q32 after a stint at Intercept Pharmaceuticals that saw him rise to the CMO role at the ...

@BiotechWorld shared
On Mar 8, 2021
Merck has better luck with 2nd COVID-19 drug attempt as it sees a positive in early molnupiravir data https://t.co/qVMPxG4eVG https://t.co/UiqzBuABIU
Open
Merck has better luck with 2nd COVID-19 drug attempt as it sees a positive in early molnupiravir data

Merck has better luck with 2nd COVID-19 drug attempt as it sees a positive in early molnupiravir data

Merck has had a torrid time with COVID-19 vaccines and a major setback with its OncoImmune-partnered pandemic med, but now, finally, it’s seeing some good news on that R&D front.

@GENbio shared
On Mar 10, 2021
A List: Check out GEN's Top 10 Biopharma Clusters. Read now: https://t.co/OTrGrdlapZ https://t.co/9IoRO2Mg1s
Open
Top 10 U.S. Biopharma Clusters

Top 10 U.S. Biopharma Clusters

Judging from the numbers reported by the nation’s top U.S. clusters, 2020 saw record-high amounts of lab space and NIH funding, as well as record-high numbers of jobs and patents. ...

@pharminews shared
On Mar 8, 2021
Baxter BioPharma Solutions and Moderna Announce Agreement for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S. https://t.co/77pG0mKl0X #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/q3J5MANKbg
Open
Baxter BioPharma Solutions and Moderna Announce Agreement for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.

Baxter BioPharma Solutions and Moderna Announce Agreement for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.

Agreement to perform fill/finish services for approximately 60–90 million doses in the U.S. this yearManufacturing will take place at Baxter BioPharma Solutions’ Indiana facilityDEERFIELD, ...

@biospace shared
On Mar 10, 2021
The pandemic has continued to evolve, as have employee expectations. Get the report to discover how employers can adequately support their employees’ changing needs. https://t.co/Fs8hg05sO8 https://t.co/2k6PPAhIP5
Open
Download the Covid in the BioPharma Workplace Report

Download the Covid in the BioPharma Workplace Report

How has Covid-19 affected the biopharma workplace? How have employee expectations and attitudes towards work and their employers changed?

@pharminews shared
On Mar 9, 2021
https://t.co/k1KQq9mjNl Welcomes Paramount Recruitment https://t.co/Fwctgn7cRN #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/f7IyZwepMv
Open
PharmiWeb.Jobs Welcomes Paramount Recruitment

PharmiWeb.Jobs Welcomes Paramount Recruitment

Paramount Recruitment in their own words... We have specific expertise in recruiting within healthcare advertising, biotechnology, pharma software, market access and HEOR in industry and ...

@CALifeSciences shared
On Mar 10, 2021
RT @JonathanWosen: San Diego biotech Sorrento Therapeutics is in the early stages of developing an antibody treatment that could work against the U.K., South Africa and Brazil strains of the coronavirus @sdut @sdbn @big4bioSD @BiocomCA @CALifeSciences https://t.co/wUQAyGAOlz
Open
San Diego biotech developing antibody treatments against new COVID strains

San Diego biotech developing antibody treatments against new COVID strains

Sorrento Therapeutics hopes to have a pair of antibodies that can stop fast-spreading strains of the coronavirus first found in the U.K., South Africa and Brazil